- Home
- YCBD vs RELI Comparison
YCBD vs RELI Comparison
Compare YCBD & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- RELI
- Stock Information
- Founded
- YCBD 2015
- RELI 2013
- Country
- YCBD United States
- RELI United States
- Employees
- YCBD N/A
- RELI N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- RELI Specialty Insurers
- Sector
- YCBD Health Care
- RELI Finance
- Exchange
- YCBD Nasdaq
- RELI Nasdaq
- Market Cap
- YCBD 3.2M
- RELI 3.4M
- IPO Year
- YCBD N/A
- RELI N/A
- Fundamental
- Price
- YCBD $0.30
- RELI $1.24
- Analyst Decision
- YCBD
- RELI Strong Buy
- Analyst Count
- YCBD 0
- RELI 1
- Target Price
- YCBD N/A
- RELI $119.00
- AVG Volume (30 Days)
- YCBD 965.3K
- RELI 31.3K
- Earning Date
- YCBD 05-14-2025
- RELI 03-06-2025
- Dividend Yield
- YCBD N/A
- RELI N/A
- EPS Growth
- YCBD N/A
- RELI N/A
- EPS
- YCBD N/A
- RELI N/A
- Revenue
- YCBD $19,220,238.00
- RELI $14,054,361.00
- Revenue This Year
- YCBD $13.00
- RELI N/A
- Revenue Next Year
- YCBD $10.00
- RELI N/A
- P/E Ratio
- YCBD N/A
- RELI N/A
- Revenue Growth
- YCBD N/A
- RELI 2.35
- 52 Week Low
- YCBD $0.21
- RELI $1.13
- 52 Week High
- YCBD $1.25
- RELI $18.53
- Technical
- Relative Strength Index (RSI)
- YCBD 47.12
- RELI 36.10
- Support Level
- YCBD $0.21
- RELI $1.13
- Resistance Level
- YCBD $0.42
- RELI $1.37
- Average True Range (ATR)
- YCBD 0.04
- RELI 0.07
- MACD
- YCBD 0.01
- RELI 0.01
- Stochastic Oscillator
- YCBD 44.43
- RELI 40.74
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.